<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-24-01552-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-24-01552-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Preclinical studies of silymarin and derivatives in vitro and in silico.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Virus</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Substrate(s)</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Method(s)</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Suggested Mechanism</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Hepatitis C virus (HCV)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin extract (MK-001)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Western blot and RT-PCR</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potentiation of the JAK-STAT antiviral signaling pathway</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B8-molecules-24-01552" ref-type="bibr">8</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin and its-derived pure compounds</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NS5B polymerase assay, luciferase reporter assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of HCV infection and the HCV-induced oxidative stress, as well as, the NS5B RdRp activity, NF-κB-dependent transcription, and T-cell receptor (TCR)-mediated proliferation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B9-molecules-24-01552" ref-type="bibr">9</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NS5B polymerase assay, luciferase reporter assay, qPCR, and western blot</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of NS5B polymerase activity and blocking viral entry and transmission</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B10-molecules-24-01552" ref-type="bibr">10</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silybin A, silybin B, and Legalon
     <sup>®</sup> SIL
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RdRp Enzyme Assay, qPCR and luciferase reporter activity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of the NS5B RNA-dependent RNA polymerase</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B11-molecules-24-01552" ref-type="bibr">11</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silibinin and Legalon
     <sup>®</sup> SIL
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCV entry assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silibinin impeded HCV endosomal trafficking and blocked CME</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B12-molecules-24-01552" ref-type="bibr">12</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silibinin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RT-PCR and luciferase reporter assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of HCV NS4B and hence the membranous web morphogenesis</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B13-molecules-24-01552" ref-type="bibr">13</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silibinin nanoparticles</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCV entry assays and pharmacokinetic studies</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of HCV cell-to-cell spread and attenuation of HCV infection of PHHs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B15-molecules-24-01552" ref-type="bibr">15</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dengue virus (DENV)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Docking to NS4B</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All three silymarin derivatives docked with high binding affinity (≥−8 kal/mol) to DENV NS4B</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B18-molecules-24-01552" ref-type="bibr">18</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Influenza A virus (IAV)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPE reduction method</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of late viral RNA synthesis</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B22-molecules-24-01552" ref-type="bibr">22</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silybin and amino acid derivatives (S0-S5)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPE reduction method and plaque assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">S0 and S3 inhibited IAV replication and disrupted the formation of the Atg5-Atg12/Atg16L complex</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B23-molecules-24-01552" ref-type="bibr">23</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Human immunodeficiency virus (HIV)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Legalon
     <sup>®</sup> SIL
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV replication in TZM-bl cells, peripheral blood mononuclear cells (PBMCs), and CEM</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Attenuating cellular functions involved in T-cell activation, proliferation, and HIV infection</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B26-molecules-24-01552" ref-type="bibr">26</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silibinin and Legalon
     <sup>®</sup> SIL
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV infection of PBMCs and CEM cells with respect to cell growth, ATP content, and metabolism</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Perturbation of T-cell metabolism in vitro; Legalon
     <sup>®</sup> SIL additionally blocked HIV infection of T-cells
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B27-molecules-24-01552" ref-type="bibr">27</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chikungunya virus (CHIKV)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPE inhibition assay, RT-PCR and Western blot</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of CHIKV replication and proteinsynthesis</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B28-molecules-24-01552" ref-type="bibr">28</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mayaro virus (MAYV)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPE inhibition, viral replication and plaque reduction assays in HepG2 cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of replication and ROS induction</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B29-molecules-24-01552" ref-type="bibr">29</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatitis B Virus (HBV) </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silibinin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HBV entry assay</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blockade of clathrin-mediated endocytosis</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B31-molecules-24-01552" ref-type="bibr">31</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
